Steris (STE) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Steris (STE) Beats Q1 Earnings and Revenue Estimates
Steris (STE) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $2 per share a year ago.
What Analyst Projections for Key Metrics Reveal About Steris (STE) Q1 Earnings
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Here's How STERIS (STE) is Placed Ahead of Q1 Earnings
STERIS' (STE) first-quarter fiscal 2025 results are likely to reflect the positives of the normalization of the Healthcare backlog, along with a core focus on pharma and MedTech.
STERIS (STE) AST Business Expands, New Offerings Aid Growth
STERIS' (STE) AST successfully offers an extensive range of sterilization modalities through a worldwide network of more than 50 contract sterilization and laboratory facilities.
Should You Hold STERIS (STE) Stock Now? Here's What to Consider
STERIS' (STE) Healthcare business and strong rebound prospects of the AST segment appear encouraging. However, macroeconomic concerns remain a challenge.
STERIS (STE) Gains From New Offerings, Macro Issues Ail
STERIS' (STE) AST successfully offers a wide range of sterilization modalities through a worldwide network of more than 50 contract sterilization and laboratory facilities.
Steris (STE) Up 2% Since Last Earnings Report: Can It Continue?
Steris (STE) reported earnings 30 days ago. What's next for the stock?
